{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-23-000447","form_type":"8-K","ticker":null,"cik":"0001593204","company_name":"Huaizhong Health Group, Inc.","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.750583+00:00","generated_at":"2026-06-17T14:58:19.799363+00:00","sec_items":["1.01","2.01","5.06","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Huaizhong Health acquires Sannong Youxuan (BVI) in stock-for-stock deal; exits shell status","bullets":["Acquired 100% of Sannong Youxuan (BVI) for 1,000,000 shares of common stock.","Target operates in software development, blockchain tech, and mobile app development, plus supplemental nutrition distribution.","Company was a shell prior to acquisition; no longer deemed a shell company post-closing.","Shares issued are subject to a 6-month lock-up agreement with the seller.","Acquisition closed on March 27, 2023; operations integrated immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-23-000447","json":"https://secwatch.observer/filing/0001640334-23-000447.json","markdown":"https://secwatch.observer/filing/0001640334-23-000447.md","text":"https://secwatch.observer/filing/0001640334-23-000447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593204/000164033423000447/0001640334-23-000447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593204/000164033423000447/huaizhong_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T14:58:19.799363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"da63591b235ddd6ad25fc7aec2213366b2dfa9ee","claim":"Huaizhong Health Group, Inc.: 公司因收购目标公司不再是壳公司 (effective 2023-03-27).","evidence_excerpt":"Prior to the acquisition of the Target on March 27, 2023, the Company was considered a shell company. Effective on March 27, 2023, upon the closing of the acquisition of the Target, the Company has changed its status as a shell company and is no longer deemed to a shell company.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593204/000164033423000447/0001640334-23-000447-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"shell status"},{"label":"Effective","value":"2023-03-27"}],"fact_type":"governance_change"},{"claim_id":"46fc54665ea3e5b588c7652ae0f982ee559cb017","claim":"Huaizhong Health Group, Inc. completed an acquisition involving Sannong Youxuan Holdings Limited (closed 2023-03-27).","evidence_excerpt":"Upon the closing of the transaction, the Company acquired 100% shares issued and outstanding ordinary shares of the Target and the Company issued 1,000,000 shares of common stock to the Seller.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593204/000164033423000447/0001640334-23-000447-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Sannong Youxuan Holdings Limited"},{"label":"Closing","value":"2023-03-27"}],"fact_type":"ma_transaction"},{"claim_id":"2fa5bbd801e8fad97d85ccab68f63f67f96673a8","claim":"Huaizhong Health Group, Inc. entered into Share Exchange Agreement with Sannong Youxuan (BVI) Limited and Sannong Youxuan Holdings Limited (effective 2023-03-27).","evidence_excerpt":"On March 27, 2023, Huaizhong Health Group Inc. (the “ Company ”) entered into a Share Exchange Agreement (the “ Share Exchange Agreement ”) with Sannong Youxuan (BVI) Limited (“ Target ”), and Sannong Youxuan Holdings Limited, the sole shareholder of the Target (the “ Seller ”), pursuant to which, among other things and subject to the terms and conditions contained therein, the Company agreed to effect an acquisition of the Target by acquiring from the Seller 100% of the ordinary shares issued and outstanding of the Target (the “ Acquisition ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593204/000164033423000447/0001640334-23-000447-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Sannong Youxuan (BVI) Limited and Sannong Youxuan Holdings Limited"},{"label":"Effective","value":"2023-03-27"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}